Track A: Green and Innovative Packaging
|
Track B: Healthcare Cold Chain Distribution
|
1.45 Redesigning Long-Haul Shippers To Reduce Costs And
Environmental Footprint
- Validation of 2-30° pack-outs for domestic distribution
- Switching from refrigerated gel packs to ambient brick gels
- 'Go Green' initiative: Recyclable and returnable pack-outs, including reduction in foam used
- Collecting and analyzing temperature data for five+ years to develop accurate profiles to test and qualify packaging
- Realizing significant costs savings
- Next steps: Other products and additional temperature ranges
Robin Turner
Director, Global Packaging Development
Medtronic
|
1.45 Management Of Stability Data For The Last Mile: A Case Presentation And Review Of Technical Report 46 "Last Mile"
- Working with quality professionals to provide sufficient information to our customers and patients
- Improving the metrics and process for evaluating product excursions for health care professionals and patients
- Tech Report 46: Distribution from Point of Dispensing to End Use in Mail Service Pharmacy
Bella Cohen
PharmD., Global Medical Information, Global Pharmaceutical Regulatory & Medical Sciences
Abbott
|
2.20 From Corn To Biodegradable Packaging: Developing Expanded
PLA (EPLA) For Moldable Cold Chain Shippers
As pharmaceutical manufacturers increase their focus on environmental
responsibility, much of the activity has centered on recycling and reusability. As
an attractive alternative, EPLA represents a potential game-changing material
innovation which would alter the way we analyze return logistics and recycling
needs and disposal. In addition to EPLA, expanded polystyrene resins are now
available with 50—75% of post-consumer, recycled content.
- Developing the EPLA Manufacturing Process
- Recycled Polystyrene Raw Material Resins
- Composting, Biodegradability and Recycling
- Cost and Performance Attributes
|
Michael Hays
Vice President
Foam Fabricators, Inc.
|
Bob Bohne
V.P., General Manager
Cold Chain Technologies, Inc.
|
|
Stephen Good
Project Manager
Packaging Engineering & Development, Abbott
|
|
2.20 Practical Issues Faced By Front-Line Staff In The Last, But
Important Leg Of The Cold Chain
- Stability practice disparity between companies and pharmacies
- Practical and economic issues with refrigeration of medications in the pharmacy and patient care areas
- How stability issues contribute to medication safety challenges
Mary E. Burkhardt
MS, RPh., Medication Safety Consultant
Medication Safety Solutions
|
2.55 Upgrading Of Traditional Cold Chain Shipping Systems
Using Custom Phase Change Materials
- New, high performance cold chain shipping systems have become available utilizing both vacuum panel insulation and custom phase change materials
- These new systems have greatly improved performance, but incur higher material costs, and may require reusability. Even if the ‘total cost’ is competitive, this represents a challenge because of the potential scope of the change & how it affects current operations & mind set
- An interim approach, bridging traditional shipping systems, and new technologies will be presented to illustrate how the two can be combined in order to gradually shift an organization to these new technologies
Ben Romero
Senior Engineer, Pharma and Packaging Development
Genentech
|
2.55 Strengthening The Wholesaler And Pharmaceutical
Manufacturer Relationship
- Discussing the value of sharing stability and shipping data
- Developing Quality Agreements with wholesale partners
- Consider sharing the financial burden
- Working together to ensure supply chain and patient safety
Chris J. Anderson
Director, Quality & Regulatory Affairs, Pharmaceutical & Medical Distribution
Cardinal Health
|
3.30 Solving Unique Cold Chain Challenges Through Available
Technology And Innovative Reusable Container Designs
While Gaining A Return On Your Investment
- Description of thermal shipper and reusability aspects
- Operational Qualification Testing: General approach, transit testing, thermal performance testing
- Live shipment test results
- Conclusions from testing results & collaboration between Pfizer and MTS
- Qualities and initiatives of the collaboration that ensured beneficial operational and financial outcomes
|
Bill Mayer
Director of Engineering
Minnesota Thermal Science
|
Michael Kreuze
Principal Engineer
Pfizer, Inc.
|
|
3.30 Panel Discussion: Proactive And Collaborative Efforts To Ensure Cold Chain Adherence Downstream And Solid Supply Partnership
- Understanding the current ‘state of play’: Measures and QA procedures currently in place at wholesaler and at pharmacies
- Educating pharmacies on the cold chain requirements and solutions available
- Addressing some of the costs involved and how to overcome budgetary issues
- Monitoring prescription drugs – but what about diagnostic devices, OTC and drugs bought on the internet?
Moderator:
Rafik H. Bishara
PhD, Technical Advisor and Chair PCCIG USA Branch
PDA
Panelists:
|
Mary E. Burkhardt, MS, RPh.,
Medication Safety Consultant
Medication Safety Solutions
|
Bella Cohen
PharmD., Global Medical Information, Global Pharmaceutical Regulatory & Medical Sciences
Abbott
|
|
Chris J. Anderson
Director, Quality & Regulatory Affairs, Pharmaceutical & Medical Distribution
Cardinal Health
|
Chris Chandler Pharm D.
Quality Assurance, Consolidated Mail Outpatient Pharmacy
US Department of Veterans Affairs
|
|